Navigation Links
Patient reports of relatives' cancer history often not accurate
Date:5/11/2011

Doctors often rely on a patient's knowledge of family medical history to estimate his or her risk of cancer. However, patient reports of family cancer history are not highly accurate, according to a study appearing May 11th online in the Journal of the National Cancer Institute.

Primary care physicians routinely ask about family history and may base their recommendationsfor screening or referrals to specialists, for instanceon the results. But it is not clear how many people in the general population have accurate information on their relatives' cancer history.

To explore this issue, Phuong L. Mai, M.D., of the National Cancer Institute and colleagues examined the accuracy of patient reports of family cancer history in the Connecticut Family Health Study. The study included a survey in which a representative sample of Connecticut residents were asked about cancer diagnoses in first- and second-degree relatives. A total of 1019 respondents provided information on cancer history for 20,578 relatives. The researchers then tried to confirm cancer history for four of the most common adult malignancies - breast, colorectal, prostate, and lung cancer - for 2,605 randomly-selected relatives.

Confirmation was obtained through state cancer registries, Medicare, death certificates, other health records and databases, and interviews directly with the relatives or their proxies.

The accuracy of reported cancer diagnoses in relatives was low to moderate and varied by type of cancer: 61.1 percent for breast cancer; 27.3 percent for colorectal cancer; 32 percent for prostate cancer; and 60.2 percent or lung cancer. In contrast, reports on relatives with no cancer were highly accurate. Reports for first-degree relatives (parents, siblings, and children) were more accurate than for second-degree relatives (grandparents, aunts, uncles, nieces, and nephews).

The authors conclude that efforts are needed to improve the accuracy of family cancer history reporting. "Given that the population from which we sampled is similar to primary care populations, the results of this study suggest that family cancer history collected in the primary care setting might be useful as an initial screening tool, and, if positive, confirmation of the reported cancers is needed for the purpose of making cancer screening recommendations or referral to a specialty clinic."

In a related editorial, Rachel A. Freedman, M.D., and Judy E. Garber, M.D., of the Dana Farber Cancer Institute in Boston say that the study highlights the limitations of relying on patient reports of family cancer histories for risk assessment. They add that the current debate on electronic medical records and patient privacy should include this issue. And they note that on-line family history tools, such as the Surgeon General's pedigree tool, genealogy websites, and Facebook pages may contribute to more accurate reporting.

"However," they write, "if we want to be able to appropriately integrate family history into personalized clinical care, studying systematic ways to enhance family history ascertainment should be a research priority."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. ICU Patients at Risk for Rare Heart Rhythm Problem
2. Young patients with chronic illnesses find relief in acupuncture
3. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
6. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
7. Behavioral therapy improves sleep and lives of patients with pain
8. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
9. MSU researcher linking breast cancer patients with alternative therapies
10. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
11. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on ... the flipper will get rich in no time. But what about the buyers of ... for the buyer of a flipped house. An email recently sent to Gary Case ...
(Date:6/28/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... attendees and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear ... CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: